TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) — (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet …
( read original story …)
The Taiwan NEWS
TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) — (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet …
( read original story …)